Ep. 71 - Brad Conlan on Building the Future of Autologous Regenerative Aesthetics

04/12/23 • 31 min

From novel treatments for hair loss and microinflammation to fat grafting and breast reconstruction, something transformative is unfolding at Bimini Health Tech, and CEO Brad Conlan is here to tell us about it.
Standing squarely at the vanguard of autologous innovation — using an individual's own cells in the name of regenerative aesthetics — Bimini seeks to marry convenience and performance with technologies that stand to reshape the way we think about aesthetic treatments.
With decades of experience in regenerative medicine, Brad offers an insider's look at everything from exosomes to stem cells and stromal vascular fraction.
Tune in to find out how Bimini is unlocking the regenerative power of the human body with autologous, personalized medicine and what the future holds for this exciting segment of the aesthetic market.
Show notes:
0:00 Intro
0:40 Aesthetics Innovation Summit
1:31 Background
3:58 Bimini origins
6:52 A symphony of healing
10:09 Current understanding of hair loss
12:30 Aesthetics as a pipeline for products that work
16:58 Fat grafting and breast reconstruction
19:39 Anticipated raise
22:57 Marrying convenience and performance
24:54 Other technologies Bimini is looking at
29:07 Crystal ball

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

Previous Episode

Ep. 70 - Dustin Sjuts on Creating the Prestige Category within Aesthetics

"If you look at the market today, most products offer the same thing to the consumer. Most companies offer the same thing, with a different spin on it, to the providers."
In its infancy, aesthetics was regarded as a premium category. But with broader adoption and sophistication, the question arises: when does a new category become a multi-faceted marketplace? More importantly, how can we properly serve today's aesthetic consumers if we paint them with a single broad brush?
With the introduction of a first-of-its-kind neuromodulator and an elite partner roll-out, Revance seeks to create an all-new prestige market within aesthetics.
In this exclusive interview, Dr. Grant Stevens sits down with President Dustin Sjuts for an up-close-and-personal glimpse into Dustin's own career path and a firsthand update on Revance's bold strategy.
A 20-year veteran with a proven track record of building and transforming healthcare companies, Dustin expounds upon Revance's commitment to approaching the market from a wholly different angle. This means not only disrupting on the clinical front but also introducing innovative new ways to support practices and, through doing so, creating an elevated end-to-end consumer experience.
Tune in to find out how Dustin and the team at Revance are shaking things up and leading the charge against commoditization within the fast-maturing category of aesthetics.

Next Episode

Ep. 72 - Meet The Father of Aesthetic Medicine | The Titans of Aesthetics Series, with Dr. David Pyott

In this exclusive interview with Dr. Grant Stevens, we are honored to present an intimate conversation with the Father of Medical Aesthetics, Dr. David Pyott.
Acknowledged as one of the top 100 performing CEO’s in the world, Dr. Pyott was the Chief Executive Officer of Allergan from 1998 until the sale of the company to Actavis in 2015. By driving innovation through investments in R&D and impeccable performance, Dr. Pyott transformed Allergan from a small eye care company into a multi-billion dollar global specialty pharmaceutical and medical device company, overseeing $68 billion in market value growth.
During his tenure Allergan launched blockbuster treatments that transformed medicine and skincare including expanding the approved uses of Botox to include treatment of migraine headaches, chronic tension headaches, cerebral palsy, severe over-active bladder and such cosmetic uses as brow furrows and crow's feet.
Throughout his career, Dr. Pyott has earned a number of honors and awards for his contributions to business, including the 2006 honor of Commander of the Most Excellent Order of the British Empire (CBE) awarded by Her Majesty the Queen for his contribution to British business excellence and management skills in the United States; the 2013 Orange County Council Semper Fidelis award for his outstanding service to the community; The Medal - University of California, Irvine's most prestigious honor in 2010; Executive Leader of the Year, UCLA Anderson School of Management 2012 and Harvard Business Review's 4th best-performing CEO in the World – 2014.
Show Notes:
0:00 Intro
1:04 Background
10:25 This little company called Allergan popped up
12:53 The very beginning of Botox
16:52 April 15, 2001: The best tax day ever
20:00 Juvéderm acquisition
24:24 The birth of medical aesthetics
26:00 Marketing mechanics: seizing opportunities, world markets
33:18 We have an absolute jewel hiding in our own safe
35:38 Market creation as a series of concentric rings
38:53 Looking better, feeling better
46:04 What David is doing now
51:47 On transcutaneous delivery
53:47 Duration of toxins
1:01:28 Natural combination of toxin and fillers
1:02:56 Plug-in devices
1:07:04 David's crystal ball